Biotechnology News

September 22, 2014

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the...

September 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Navitor Pharmaceuticals has been named by FierceBiotech as one of 2014’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.

September 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals Announces Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the ESMO 2014 Congress

September 22, 2014

EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical Announces the Addition of K. Adam Dubov, Esq. to Scientific Advisory Board

September 22, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) today announced its updated strategy and plan to restructure its operations and reduce costs.

September 22, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Published findings from a research collaboration between miRagen Therapeutics, Inc. and Yale University demonstrate that miRagen’s promiR-29 reverses fibrosis in a mouse model of pulmonary fibrosis.

September 22, 2014

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Two Kansas Federally Qualified Health Centers have selected eClinicalWorks electronic health records solution and revenue cycle management for use across their combined 12 clinic locations.

September 22, 2014

PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced shipping its recently approved Oxycodone Hydrochloride Oral Solution USP, 100 mg per 5 mL. According to IMS, annualized sales of Oxycodone...

September 22, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that it has entered into...

September 22, 2014

BRISBANE, Australia & COPENHAGEN, Denmark--(BUSINESS WIRE)--Clinical Network Services (CNS) and Ventac Partners sign cooperative partnership

September 22, 2014

PLEASANTON, Calif.--(BUSINESS WIRE)--The life sciences industry’s largest TMF survey to date reveals an increase in the number of clinical trial sponsors that plan to provide auditors with remote access to their eTMF.

September 22, 2014

TRENTON, N.J.--(BUSINESS WIRE)--BioNJ releases first-of-its-kind report documenting the ongoing growth of the biotechnology sector in NJ and assesses the contributions of the entirety of the life sciences sector to NJ economy.

September 22, 2014

DARMSTADT, Germany & ST. LOUIS, Mo.--(BUSINESS WIRE)--Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion (€13.1 billion) Acquisition expands Merck Millipore’s global reach, increasing the company...

September 22, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PROVECTUS BIOPHARMACEUTICALS APPOINTS CHRISTOPHER KAPLAN TO ITS STRATEGIC ADVISORY BOARD

September 22, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical announced today the publication of new data comparing the LINX® Magnetic Sphincter Augmentation Device and laparoscopic fundoplication surgery in 249 patients. Data from this study significantly...

September 22, 2014

OSLO, Norway--(BUSINESS WIRE)--Reference is made to the announcement published on 16 September 2014 in which Nordic Nanovector AS (the “Company”) announced the final result of its subsequent repair offering (the "Offering"). The share capital...

September 22, 2014

PARIS--(BUSINESS WIRE)--NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today the opening of its first US office in Boston,...

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic pulmonary fibrosis (IPF) treated for 48 weeks with the investigational drug...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 21st Annual NewsMakers in the Biotech Industry Conference...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30 a.m. EDT in New York

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative company specialized in the development of drugs for orphan oncology...

September 19, 2014

JACKSONVILLE, Fla.--(BUSINESS WIRE)--AACE publishes its "Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease," including an algorithm and therapeutic interventions, in its peer-reviewed journal, Endocrine Practice

September 19, 2014

JACKSONVILE, Fla.--(BUSINESS WIRE)--AACE plans to address issues with quality, safety, access, and post- marketing surveillance of optimal glucose monitoring for glucose strips and continuous glucose monitors for patients with diabetes

September 19, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--OncoCyte Corporation, a subsidiary of BioTime, Inc. (NYSE MKT: BTX), today announced that Chief Executive Officer Joseph Wagner, Ph.D. is scheduled to present at the inaugural BTIG Emerging Technologies in...

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that management will present a company overview at...

September 19, 2014

WASHINGTON--(BUSINESS WIRE)--The breakout session program for BIO's ninth annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy, to be held in San Diego in December 2014, will focus on technology commercialization.

September 19, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., to host conference call & live audio webcast on Sept 24, 2014 to provide corporate update and discuss financial results

September 19, 2014

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that Tuomo Pätsi has been appointed President of the Europe, Middle East and Africa (EMEA) region...

September 19, 2014

SEOUL, South Korea--(BUSINESS WIRE)--Over the next three years, 80 Uruguayan genomes will be sequenced and analyzed in order to uncover the genetic basis for diseases in Uruguay through the Urugenomes Project.

September 19, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Frazier Healthcare, a leading provider of venture and growth buyout capital to emerging healthcare companies, announced today that David Socks has joined the Frazier Life Sciences team as a Venture Partner...

September 19, 2014

RICHMOND, Va. & LJUBLJANA, Slovenia & SYDNEY--(BUSINESS WIRE)--AmpliPhi BioSciences Corporation (OTC:APHB) (“AmpliPhi”), the leader in the discovery and development of bacteriophage based therapies to treat drug resistant bacterial...

September 19, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--Jinchi Biotech Ltd. had opened its ANDRIAS E-Commerce Flagship Store in Tmall.com (ANDRIAS Tmall Flagship Store Website: XIANGNI.TMALL.COM). As the unique brand of giant salamander active skincare products,...

September 19, 2014

BURR RIDGE, Ill.--(BUSINESS WIRE)--Project management consulting firm IPM named Great Place to Work for fifth consecutive year.

September 19, 2014

INGELHEIM & TÜBINGEN, Germany--(BUSINESS WIRE)--Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy

September 19, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the European Commission has granted marketing authorization for Zydelig® (idelalisib), 150 mg tablets, a first-in-class oral treatment for two...

September 19, 2014

DUBLIN--(BUSINESS WIRE)--ICON plc, (Nasdaq: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40 million buyback of the Company...

September 19, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Please find a notice of an extraordinary general meeting of DiaGenic ASA (OSE:DIAG) to be held on 9 October at 10:00 CET, at Sjølyst Plass 2, Oslo....

September 19, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Alexion announced that researchers presented data from the open-label extension phases of two Phase 2 studies of asfotase alfa in paediatric patients with hypophosphatasia at the 53rd ESPE Meeting.

September 18, 2014

WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and Left Atrial Appendage Management (LAAM), today announced the introduction of the AtriClip® FLEX, a...

September 18, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea's Lymphoseek lymphatic mapping imaging agent received Orphan Drug Designation from FDA for use in sentinel lymph node detection in patients with head and neck cancer.

September 18, 2014

MONTIGNY LE BRETONNEUX, France--(BUSINESS WIRE)--Bertin Technologies launches Precellys ® Evolution, its brand new biological sample homogenizer in the Precellys range.

September 18, 2014

PARIS--(BUSINESS WIRE)--Regulatory News : Cegedim, a global technology and services company in the healthcare field, announces that its 2014 Half-Year Financial Report has been published in compliance with Autorité des Marchés Financiers (AMF)....

September 18, 2014

BERLIN--(BUSINESS WIRE)--EBS Technologies reports that a clinical study published in Neurology® validates electrical brain stimulation technology designed to expand the visual field of patients with impaired vision

September 18, 2014

DOYLESTOWN, Pa.--(BUSINESS WIRE)--FlowMetric, Inc., Forms New Affiliate Company, FlowMetric Diagnostics Inc. to Develop Advanced Diagnostics from Flow Cytometry Platform

September 18, 2014

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--RxAdvance, an innovative pharmacy benefit management (PBM) company, has expanded its executive management team with another industry veteran, Terry A. Ramey, who joins as Executive Vice President, Business...

September 18, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience CEO Michelle Dipp Named Outstanding Young Leader